USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein

Biochem J. 2017 May 4;474(10):1653-1668. doi: 10.1042/BCJ20160304.

Abstract

Deubiquitinases (DUBs) are key regulators of complex cellular processes. HIV-1 Tat is synthesized early after infection and is mainly responsible for enhancing viral production. Here, we report that one of the DUBs, USP7, stabilized the HIV-1 Tat protein through its deubiquitination. Treatment with either a general DUB inhibitor (PR-619) or USP7-specific inhibitor (P5091) resulted in Tat protein degradation. The USP7-specific inhibitor reduced virus production in a latently infected T-lymphocytic cell line J1.1, which produces large amounts of HIV-1 upon stimulation. A potent increase in Tat-mediated HIV-1 production was observed with USP7 in a dose-dependent manner. As expected, deletion of the USP7 gene using the CRISPR-Cas9 method reduced the Tat protein and supported less virus production. Interestingly, the levels of endogenous USP7 increased after HIV-1 infection in human T-cells (MOLT-3) and in mammalian cells transfected with HIV-1 proviral DNA. Thus, HIV-1 Tat is stabilized by the host cell deubiquitinase USP7, leading to enhanced viral production, and HIV-1 in turn up-regulates the USP7 protein level.

Keywords: HIV-1; deubiquitination; protein degradation; transactivation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminopyridines / pharmacology
  • Anti-HIV Agents / pharmacology
  • CRISPR-Cas Systems
  • Cell Line
  • Enzyme Induction / drug effects
  • Enzyme Inhibitors / pharmacology
  • Genes, Reporter / drug effects
  • HEK293 Cells
  • HIV-1 / drug effects
  • HIV-1 / physiology*
  • Host-Pathogen Interactions / drug effects
  • Humans
  • Jurkat Cells
  • Protein Stability / drug effects
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / metabolism
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • T-Lymphocytes / virology
  • Thiocyanates / pharmacology
  • Thiophenes / pharmacology
  • Ubiquitin Thiolesterase / antagonists & inhibitors
  • Ubiquitin Thiolesterase / genetics
  • Ubiquitin Thiolesterase / metabolism*
  • Ubiquitin-Specific Peptidase 7
  • Ubiquitination / drug effects
  • Virus Replication / drug effects
  • tat Gene Products, Human Immunodeficiency Virus / chemistry
  • tat Gene Products, Human Immunodeficiency Virus / genetics
  • tat Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • 2,6-diaminopyridine-3,5-bis(thiocyanate)
  • Aminopyridines
  • Anti-HIV Agents
  • Enzyme Inhibitors
  • P5091
  • Recombinant Fusion Proteins
  • Thiocyanates
  • Thiophenes
  • tat Gene Products, Human Immunodeficiency Virus
  • USP7 protein, human
  • Ubiquitin Thiolesterase
  • Ubiquitin-Specific Peptidase 7